Aurobindo Launches Cheap Anti-Aids Drug

Image
BUSINESS STANDARD
Last Updated : Jan 28 2013 | 12:58 AM IST

Aurobindo Pharma, in a bid to make HIV treatment more affordable through government-sponsored institutions, has launched generic versions of anti-AIDS drugs at a price which is lower by about 50 per cent compared with branded versions. The company, which claims to be the only company in the country to have come out with generic versions of anti-AIDS drugs, in a release said that all the 11 combinations that are being available for the treatment of HIV will also available in the generic form.

However, generic drugs are presently offered only through government-sponsored institutions.

Generic versions are made available at a cheaper price since these are exempted from all kinds of duties, the benefit available to life-saving drugs. Another cost advantage for Aurobindo is that it also produces bulk forms of all these drugs.

Aurobindo, which has been supplying branded drugs to all the government-sponsored State AIDS Control societies for the last one year, now hopes to get a major chunk of the institutional purchases.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jul 05 2002 | 12:00 AM IST

Next Story